Hormone Therapy Raises Women's Risk for Bone Loss

Healthy postmenopausal women who took 25 mg of a type of aromatase inhibitor called exemestane daily for two years experienced bone loss in their forearm and ankle, the study published in the journal Lancet found.

Read The Full Story

Share: Digg - del.icio.us - Stumble It - News Vine - buzz-it

Source: ABC Published: Monday 06th of February 2012

Members: Save This Story